HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00
Cytokinetics (NASDAQ:CYTK – Free Report) had its target price lowered by HC Wainwright from $94.00 to $90.00 in a research note issued to investors on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently commented on CYTK. Mizuho decreased their […]
More Stories
MAI Capital Management Sells 1,719 Shares of Vanguard Mega Cap Value ETF (NYSEARCA:MGV)
MAI Capital Management decreased its position in Vanguard Mega Cap Value ETF (NYSEARCA:MGV – Free Report) by 5.6% during the...
Recent Research Analysts’ Ratings Updates for GFL Environmental (GFL)
Several brokerages have updated their recommendations and price targets on shares of GFL Environmental (NYSE: GFL) in the last few...
S&P Global Inc. (NYSE:SPGI) Shares Sold by Wrapmanager Inc.
Wrapmanager Inc. trimmed its position in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 11.6% during the third...
Wrapmanager Inc. Buys 429 Shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK)
Wrapmanager Inc. grew its position in shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK – Free Report) by 5.0% during the...
AMG National Trust Bank Trims Stock Position in Expedia Group, Inc. (NASDAQ:EXPE)
AMG National Trust Bank cut its stake in Expedia Group, Inc. (NASDAQ:EXPE – Free Report) by 26.2% in the 3rd...
Fifth Third Wealth Advisors LLC Invests $1.72 Million in NVR, Inc. (NYSE:NVR)
Fifth Third Wealth Advisors LLC purchased a new stake in shares of NVR, Inc. (NYSE:NVR – Free Report) in the...